Clinical Trial Update: A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 study assessed the safety and tolerability of an inhaled RV568 formulation in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• RV568

Snippet

Sponsor: Respivert Ltd | Conditions: COPD, Healthy Volunteers | Phase 1 | Status: COMPLETED